Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy.
Metabolic-associated fatty liver disease (MAFLD) is the hepatic manifestation of metabolic syndrome and affects about 55% of people living with diabetes. MAFLD has been shown to be an individual risk factor for cardiovascular disease and its associated mo..... Read More